Prescient Therapeutics LimitedASX: PTX

PTX secures EU Orphan Drug Designation for PTX-100 in CTCL

Nov 19, 2025 at 3:23 AM UTC · Issued by Prescient Therapeutics Limited

Prescient Therapeutics Ltd has released a press release.

View Attachment

Earlier from Prescient Therapeutics

All Prescient Therapeutics news releases